New research demonstrates konjac glucomannan gel forms enhance Akkermansia microbiota and improve metabolic markers in obese mice, with implications for personalized human nutrition strategies. A 2024...
New clinical studies demonstrate konjac glucomannan’s ability to lower LDL cholesterol and fasting glucose while enhancing gut microbiota diversity, offering a novel dietary strategy for metabol...
New research reveals frozen gel konjac glucomannan outperforms other forms in boosting gut microbiota diversity while effectively regulating glucose and lipid metabolism. Cutting-edge studies demonstr...
New research reveals konjac glucomannan’s unique ability to modulate gut microbiota and improve metabolic markers through different intake forms, offering novel obesity management strategies. Cu...
New research reveals KGM sol reduces insulin resistance 40% and boosts GLP-1 2.1-fold in obese mice, with emerging clinical evidence supporting human applications. Groundbreaking mouse studies demonst...
Recent studies demonstrate konjac glucomannan’s dose-dependent effects on metabolic health, gut microbiota diversity, and appetite control in obese mice, with implications for human dietary stra...
